PRESS RELEASE published on 03/08/2025 at 19:00, 1 year 6 months ago Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Positive pivotal data for Dupixent in bullous pemphigoid presented at AAD, showing significant disease remission and reduction in severity, itch, and medication use. Regulatory submissions under review in US and EU Dupixent Type 2 Inflammation Bullous Pemphigoid AAD Sustained Remission
BRIEF published on 02/25/2025 at 07:05, 1 year 7 months ago Sarclisa Gains Approval in Japan for Multiple Myeloma Treatment Multiple Myeloma Sarclisa Approval Sanofi Oncology Japan Healthcare IMROZ Study
BRIEF published on 02/25/2025 at 07:05, 1 year 7 months ago Sarclisa obtient l'approbation au Japon pour le traitement du myélome multiple Myélome Multiple Étude IMROZ Approbation De Sarclisa Sanofi Oncologie Système De Santé Au Japon
PRESS RELEASE published on 02/25/2025 at 07:00, 1 year 7 months ago Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Sarclisa approved in Japan for newly diagnosed multiple myeloma patients, offering new treatment options based on positive IMROZ phase 3 study results Oncology Japan Multiple Myeloma Sarclisa IMROZ Study
PRESS RELEASE published on 02/24/2025 at 21:27, 1 year 7 months ago Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE published on 02/24/2025 at 21:27, 1 year 7 months ago Sanofi: Disclosure of trading in own shares
BRIEF published on 02/22/2025 at 08:35, 1 year 7 months ago Sanofi-Teva : Promesses du Duvakitug pour les Maladies Inflammatoires de l'Intestin Maladie De Crohn Colite Ulcéreuse Duvakitug RELIEVE UCCD Sanofi-Teva
BRIEF published on 02/22/2025 at 08:35, 1 year 7 months ago Sanofi-Teva: Duvakitug Promises for Inflammatory Bowel Diseases Ulcerative Colitis Crohn's Disease Duvakitug RELIEVE UCCD Sanofi-Teva
PRESS RELEASE published on 02/22/2025 at 08:30, 1 year 7 months ago Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn Nouvelles données sur duvakitug présentées par Sanofi et Teva pour traiter colite ulcéreuse et maladie de Crohn au Congrès ECCO 2025, Berlin Maladie De Crohn Sanofi Colite Ulcéreuse Teva Duvakitug
PRESS RELEASE published on 02/22/2025 at 08:30, 1 year 7 months ago Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease Sanofi and Teva Pharmaceuticals present new detailed data from the RELIEVE UCCD study on duvakitug's efficacy in ulcerative colitis and Crohn's disease at ECCO 2025, demonstrating potential for phase 3 program in H2 2025 Ulcerative Colitis Sanofi Teva Pharmaceuticals Crohn's Disease RELIEVE UCCD Study
Published on 09/26/2026 at 01:00, 1 day 17 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 19 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 3 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 56 minutes ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 2 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 2 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 2 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 10 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026